NIH clinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma
| Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
12/28/2022 11:00 AM EST ASPS is an extremely rare cancer that affects mostly adolescents and young adults. |


Comments
Post a Comment